旅行疫苗市场概况、增长、趋势、分析、研究报告(2021-2031 年)

  • Report Code : TIPRE00007439
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Travel Vaccines Market Drivers and Opportunities [2021-2031]

Buy Now

旅行疫苗市场规模预计将从 2023 年的 42 亿美元增至 2031 年的 92 亿美元。预计 2023-2031 年期间市场复合年增长率将达到8.7%。旅行疫苗数字化可能仍是市场的主要趋势。

旅行疫苗市场分析

疫苗接种运动或免疫计划将为未来几年旅行疫苗市场的增长提供丰厚的机会。大多数国家都已强制要求接种多种传染病的疫苗。然而,大多数中低收入国家缺乏对疫苗接种的认识。因此,一些发展中国家开展了疫苗接种运动的宣传活动。联合国儿童基金会(UNICEF)就是这样一个例子,它在萨摩亚、汤加、图瓦卢和瓦努阿图等国家建立了一个疫苗项目,以抑制轮状病毒、肺炎球菌结合疫苗和人乳头瘤病毒(HPV)。该项目由亚洲开发银行( ADB )资助亚行已部署 2970 万美元用于加强太平洋项目中新疫苗的覆盖系统。该项目为发展中国家的90,700 名儿童接种了肺炎疫苗,近 71,600 名儿童接种了轮状病毒疫苗,84,200 名青春期女孩接种了 HPV 感染疫苗。上述因素是 2021-2031 年期间市场大幅增长的重要因素。旅行疫苗的数字化可能仍是市场的主要趋势。

旅行疫苗市场概况

传染病发病率的上升推动了市场的增长。例如,COVID-19 大流行已成为对公共卫生的威胁。根据世界卫生组织( WHO) 的报告,截至 2021 年 5 月 1 日,已有超过 153 万人受到大流行的影响,死亡人数接近 320 万。大流行期间采取了多项紧急行动;其中,COVAX倡议得到了积极实施。各地区政府都要求在国内和国外旅行的人接种疫苗。COVID-19 大流行对旅行疫苗做出了很大贡献,并促进了市场的增长。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

旅行疫苗市场:

旅行疫苗市场
  • Travel Vaccines Market
    复合年增长率(2023 - 2031)
    8.7%
  • 2023 年市场规模
    42 亿美元
  • 2031 年市场规模
    92 亿美元

市场动态

增长动力
  • 传染病发病率上升推动市场增长
  • 国际旅行的增加加速了对旅行疫苗的需求,预计这将有利于市场增长
未来的趋势
  • 旅行疫苗的数字化可能仍是市场的主要趋势。
机会
  • 旅行疫苗研发投资不断增加,提供有利可图的市场机会

关键人物;主力;重要一员

  • 葛兰素史克
  • 默克公司
  • 赛诺菲
  • 诺华
  • 辉瑞
  • Dynavax 技术
  • 新兴生物解决方案公司
  • 雅培
  • 印度生物科技公司
  • 瓦尔内瓦

区域概况

Travel Vaccines Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Travel Vaccines Market产品
  • 甲型肝炎
  • 乙型肝炎
  • 脑膜炎球菌疫苗
  • 德普特
  • 黄热病
  • 伤寒
  • 日本脑炎
  • 麻疹
  • 腮腺炎
  • 风疹
Travel Vaccines Market应用
  • 国内游和出境游
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

旅行疫苗市场驱动因素和机遇

国际旅行增长加速,旅行疫苗需求增加,利好市场

国际旅行者增加了传播罕见疾病的机会。因此,旅行前接种疫苗对于确保全球公共卫生和帮助旅行者在旅行期间和旅行后保持健康至关重要。建议旅行者接种的疫苗因某些因素而异。这些因素包括旅行者的年龄、免疫史、现有医疗状况、目的地、计划活动、旅行时间和性质以及进入访问国的法律要求。此外,国际旅行的婴儿应主要接种白喉、破伤风、无细胞百日咳、灭活脊髓灰质炎和乙型流感嗜血杆菌疫苗,或不接种乙肝 (DTaP-IPV-Hib 或 DTaP-HB-IPV-Hib) 疫苗和肺炎球菌结合疫苗。例如,对于在加拿大境外旅行的儿童,第一剂麻疹-腮腺炎-风疹 (MMR) 疫苗应比平时更早接种。因此,传染病的增加加速了对旅行疫苗的需求,成为全球旅行疫苗市场份额的主要驱动力。

研发活动将带来丰厚的市场机会

  • 2021 年 12 月,Emergent BioSolutions Inc. 宣布其第一阶段研究 EBS-UFV-001 的首位参与者已接受给药,该研究评估了该公司研究的通用流感候选疫苗的安全性、耐受性和免疫原性。当前版本的流感候选疫苗含有多种成分,旨在诱导针对甲型流感病毒的广泛和超季节性免疫力。
  • 2020 年 2 月,雅培推出了一种新型灭活四价流感疫苗这种新疫苗是印度首款能够预防四种病毒株的亚单位疫苗。它是印度唯一一种获准用于 3 岁以下儿童的 0.5 毫升四价流感疫苗。

因此,不断增加的研发活动将对旅行疫苗市场产生积极影响,因为它有机会开发先进的产品。

旅行疫苗市场报告细分分析

有助于得出旅行疫苗市场分析的关键部分是类型、应用和最终用户。

  • 根据产品,旅行疫苗市场细分为甲型肝炎、乙型肝炎、脑膜炎球菌疫苗、百白破、黄热病、伤寒、日本脑炎、麻疹、腮腺炎和风疹 (MMR)、狂犬病、脊髓灰质炎、流感、水痘和带状疱疹、霍乱等。甲型肝炎疫苗在 2023 年占据了最大的市场份额。
  • 根据用途,市场分为国内旅行和出境旅行。出境旅行部分在 2023 年占据了最大的市场份额。

旅行疫苗市场份额按地区分析

旅行疫苗市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美和中美。

北美占据了市场主导地位。在北美地区,美国占据了旅行疫苗市场的最大份额。该地区顶级制造商的存在及其创新产品是其占据市场主导地位的因素。预计亚太地区将在未来几年以最高的复合年增长率增长。

旅行疫苗市场报告范围

报告属性细节
2023 年的市场规模42亿美元
2031 年市场规模92亿美元
全球复合年增长率(2023 - 2031)8.7%
历史数据2021-2022
预测期2024-2031
涵盖的领域按产品
  • 甲型肝炎
  • 乙型肝炎
  • 脑膜炎球菌疫苗
  • 德普特
  • 黄热病
  • 伤寒
  • 日本脑炎
  • 麻疹
  • 腮腺炎
  • 风疹
按应用
  • 国内游和出境游
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 葛兰素史克
  • 默克公司
  • 赛诺菲
  • 诺华
  • 辉瑞
  • Dynavax 技术
  • 新兴生物解决方案公司
  • 雅培
  • 印度生物科技公司
  • 瓦尔内瓦
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

旅行疫苗市场新闻和最新发展

旅行疫苗市场通过收集一手和二手研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下列出了旅行疫苗市场的一些发展情况:

  • Bavarian Nordic A/S 宣布与 Emergent Biosolutions Inc. 合作,收购两种已上市的旅行疫苗“Vivotif”(用于预防伤寒)和“Vaxchora”(用于预防霍乱)以及用于预防基孔肯雅病毒的 3 期候选疫苗。此次收购不仅旨在扩大商业产品组合并在旅行疫苗领域占据领先地位,而且还通过有前景的后期疫苗加强公司在产品线中的地位。(来源:Bavarian Nordic A/S,网站,2023 年 2 月)。

旅行疫苗市场报告覆盖范围和交付成果

“旅行疫苗市场规模和预测(2021-2031)”报告对市场进行了详细分析,涵盖以下领域:

  • 范围内涵盖的所有主要细分市场的全球、区域和国家/地区旅行疫苗市场规模和预测
  • 旅行疫苗市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 旅行疫苗市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及旅行疫苗市场的最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region dominated the travel vaccines market in 2023?

North America region dominated the travel vaccines market in 2023.

What are the driving factors impacting the travel vaccines market?

Rising international travel accelerate demand for travel vaccines is one of the most influential factors responsible for market growth.

What are the future trends of the travel vaccines market?

Digitalization for travel vaccines to remain as a key trend for travel vaccines market.

Which are the leading players operating in the travel vaccines market?

GSK, Merck & Co., Inc., Sanofi, Novartis, Pfizer, Dynavax Technologies, Emergent Biosolutions Inc., Abbott, Bharat Biotech, and Valneva are the key players in the travel vaccines market.

What would be the estimated value of the travel vaccines market by 2031?

The estimated value of travel vaccines market accounted US$ 9.2 billion in 2031.

What is the expected CAGR of the travel vaccines market?

The CAGR for travel vaccines accounted 8.7% during 2023-2031.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..